Cite
HARVARD Citation
Tan, R. et al. (2022). Impact of Immune Checkpoint Inhibitors on COVID-19 Severity in Patients with Cancer. Oncologist. pp. 236-243. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Tan, R. et al. (2022). Impact of Immune Checkpoint Inhibitors on COVID-19 Severity in Patients with Cancer. Oncologist. pp. 236-243. [Online].